GSK PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.15 USD | -1.38% |
|
+0.60% | +21.83% |
| 10:53am | Rate outlook weighs on equities |  |
| 10:37am | GSK: successful verdict in Zantac case | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 728B | ||||||
| 603B | ||||||
| 360B | ||||||
| 332B | ||||||
| 279B |
- Stock Market
- Equities
- GSK Stock
- GSK Stock
- Charts GSK plc
- Sector Chart
